Tectonic Therapeutic (TECX) Non Operating Investment Income (2017 - 2018)
Tectonic Therapeutic (TECX) reported Non Operating Investment Income of -$1.0 million for Q2 2018, down 34633.33% year-over-year from N/an in Q2 2017, and down 77.51% quarter-over-quarter from -$587000.0 in Q1 2018.
Tectonic Therapeutic (TECX) Non Operating Investment Income (2017 - 2018) Analysis & Trends
Tectonic Therapeutic (TECX) has 2 years of Non Operating Investment Income data on file, last reported at -$1.0 million in Q2 2018.
- Non Operating Investment Income for Q2 2018 came in at -$1.0 million, down 34633.33% year-over-year; the trailing twelve-month figure through Sep 2019 was -$1.0 million (up 42.72% YoY), and the FY2018 annual result was -$1.6 million, down 475.62% from the prior year.
- Non Operating Investment Income eased to -$1.0 million in Q2 2018 per TECX's latest filing, from -$587000.0 in the prior quarter.
- Over five years, Non Operating Investment Income peaked at -$3000.0 in Q2 2017 and troughed at -$1.0 million in Q2 2018.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Operating Investment Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 762,369.55 Bn | 762,369.51 Bn | - | - |
| 2 | Belite Bio | 55,096.00 Bn | 55,096.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,755.80 Bn | 17,755.79 Bn | - | 235,807.00 |
| 4 | Legend Biotech | 3,486.00 Bn | 3,485.71 Bn | 242.10 Mn | - |
| 5 | Akari Therapeutics | 1,737.42 Bn | 1,737.41 Bn | - | 230,000.00 |
| 6 | Evaxion A | 1,551.28 Bn | 1,551.26 Bn | - | - |
| 7 | Psyence Biomedical | 227.32 Bn | 227.31 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 110.84 Bn | 103.59 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.71 Bn | 91.71 Bn | - | - |
| 10 | Tectonic Therapeutic | 528.16 Mn | 291.27 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2018 | -1.04 Mn |
| Jun 30, 2018 | -1.04 Mn |
| Mar 31, 2018 | -587,000.00 |
| Mar 31, 2018 | -587,000.00 |
| Dec 31, 2017 | -190,000.00 |
| Dec 31, 2017 | -190,000.00 |
| Sep 30, 2017 | -58,000.00 |
| Sep 30, 2017 | -58,000.00 |
| Jun 30, 2017 | -3,000.00 |
| Jun 30, 2017 | -3,000.00 |